http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012009208-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28b3e760cab0a746f1359ca34d0a3b5e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0637
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2011-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c61edf7c3039cf9e179f107cb60e571d
publicationDate 2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2012009208-A1
titleOfInvention USE OF MEMBRANE ATTACK COMPLEX (MAC) AND IMMUNE COMPLEXES (ICs) TO ACTIVATE T-CELLS AND THE GENERATION OF REGULATORY T CELLS
abstract The invention describes the use of antigen-antibody complexes also known in the field as immune complexes to activate T cells and their potential to differentiate them into effector T cells for use in therapy. It also describes a process to achieve benefit from disrupting this T cell activation mediated by antigen-antibody complex and sublytic MAC of the complement system.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11365392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018024894-A1
priorityDate 2010-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006067912-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136033793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID425562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136069385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11196273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127722233

Total number of triples: 41.